Navigation Links
New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes
Date:11/21/2008

target="_blank">www.merck.com.

Forward-Looking Statement

This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and involve risks and uncertainties, which may cause results to differ materially from those set forth in the statements. The forward-looking statements may include statements regarding product development, product potential or financial performance. No forward-looking statement can be guaranteed and actual results may differ materially from those projected. Merck undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. Forward-looking statements in this press release should be evaluated together with the many uncertainties that affect Merck's business, particularly those mentioned in the risk factors and cautionary statements in Item 1A of Merck's Form 10-K for the year ended Dec. 31, 2007, and in any risk factors or cautionary statements contained in the Company's periodic reports on Form 10-Q or current reports on Form 8-K, which the Company incorporates by reference.

JANUVIA™ is a trademark of Merck & Co., Inc.

Prescribing information and patient product information for JANUVIA are attached.

  • A1C is a measure of a person's average blood glucose over a two- to three-month period.

JANUVIA™

(sitagliptin) Tablets

9762706

HIGHLIGHTS OF PRESCRIBING INFORMATION

These highlights do not include all the information needed to use JANUVIA safely and effectively. See full prescribing information for JANUVIA.

JANUVIA™ (sitagliptin) Tablets

Initial U.S. Appro
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine news :

1. STAAR Surgical Forms Team of Leading Ophthalmic Surgeons to Study the Use of Collamer(R) Material for Accommodating Intraocular Lenses
2. Landmark study defines benefits of early HIV testing and treatment for infected infants
3. Study identifies causes of bone loss in breast cancer survivors
4. New Study by BioTrends Highlights Practice Management Shifts Among Canadian Nephrologists
5. Study Suggests Need for More Aggressive Outpatient Monitoring of Patients Hearts When Cause of Stroke is Unclear
6. Rutgers researchers study cites media violence as critical risk factor for aggression
7. Brigham and Womens Researchers Partner with Vocantas to use CallAssure in Clinical Research Study
8. Analyst Available to Comment on New JUPITER Study That Shows AstraZenecas Crestor Significantly Reduces CV Risk
9. New Study Finds CO2 Ablative Fractional Resurfacing Safe And Effective For Deep Acne Scarring
10. Study investigates Gore-tex-type device to stop strokes and mini-strokes
11. The smart way to study
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
 New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 
(Date:9/15/2014)... Today, Zane Benefits, the #1 Online Health Benefits ... radio show. , According to Zane Benefits, health ... doesn’t make sense to choose a “one size fits ... and employee as much as 60 percent on health ... Speaking on Business , Chris Redgrave, highlights the rising ...
(Date:9/15/2014)... UC San Francisco researchers have used brain scans to ... a possible tool to spot children with dyslexia and ... , In the United States, children usually learn to ... proficient readers by third grade, according to the authors. ... kindergarteners as they were learning to read formally at ...
(Date:9/15/2014)... from the prospective Prostate, Lung, Colorectal and Ovarian (PLCO) ... baldness affecting both the front and the crown of ... increased risk of developing aggressive prostate cancer (usually indicates ... to non-aggressive prostate cancer) later in life, compared to ... between other patterns of baldness and prostate cancer risk. ...
(Date:9/15/2014)... 2014 In order to provide predictability ... act conjointly to quantify, define and model medical practice. ... integral part of medical care. , The Journal of ... conducted by the non-profit Institute of BioAcoustic Biology, located ... math can be much more than a measurement tool; ...
(Date:9/15/2014)... Amy Norton HealthDay ... A relatively small number of medications are responsible for sending ... a U.S. government study finds. Each year between 2007 ... were hospitalized after getting a hold of family members, medication, ... "Three-quarters of those children were just 1 or ...
Breaking Medicine News(10 mins):Health News:Zane Benefits Featured on Zions Bank Speaking on Business 2Health News:Study first to use brain scans to forecast early reading difficulties 2Health News:Certain form of baldness at age 45 linked to higher risk of aggressive prostate cancer 2Health News:Math as Medicine: The Promise of Frequency Domain BioMarkers as a Template to Predict, Enchance and Promote Optimal Health 2Health News:Math as Medicine: The Promise of Frequency Domain BioMarkers as a Template to Predict, Enchance and Promote Optimal Health 3Health News:Small Number of Drugs Behind Kids' Accidental Poisonings: CDC 2Health News:Small Number of Drugs Behind Kids' Accidental Poisonings: CDC 3
... Bulletin Board: GXYF), a leading developer and marketer of,cheese ... today announced that it will host an investor conference ... the 2008 fiscal year at,11:00 a.m. EST on Friday, ... results before the market opens the same day., ...
... ROCHESTER, Minn. -- Liver transplant is a life saving ... the need for donor livers far exceeds the supply. ... a donor liver will receive one, and some patients ... Clinic Proceedings, physicians explore how the current system for ...
... for,employers throughout the world are expected to accelerate ... of insurance companies conducted by Watson,Wyatt Worldwide, a ... in a vast majority of countries, medical cost ... Nearly three-fourths (71 percent) of respondents expect higher ...
... Co-Founder Todd Rosengart Offers Lifesaving Tips in the Fight ... ... data released from,the Center for Disease Control indicates that deaths resulting ... such as obesity, high blood pressure and high cholesterol remain on,the ...
... also available in German . , In ... childless against their will. The microscopic procedure significantly improves the ... discovered by scientists at the University of Bonn together with ... 124 women. Up to now, the desire to have a ...
... Reston, Va.Researchers involved in a large, multi-institutional study comparing ... tomography (CT) in the characterization of lung nodules found ... or not a nodule was malignant. , CT and ... nodules (SPNs) as benign or malignant, said James W. ...
Cached Medicine News:Health News:Galaxy Nutritional Foods Announces Third Quarter FY2008 Earnings Conference Call for Friday, February 8, 2008 2Health News: Mayo Clinic Proceedings contributors discuss impact of donor organ allocation system 2Health News: Mayo Clinic Proceedings contributors discuss impact of donor organ allocation system 3Health News:Medical Cost Increases to Accelerate Worldwide Over Next Five Years, Watson Wyatt Poll Finds 2Health News:Medical Cost Increases to Accelerate Worldwide Over Next Five Years, Watson Wyatt Poll Finds 3Health News:Vitals.com 'Goes Red' for American Heart Month 2Health News:Vitals.com 'Goes Red' for American Heart Month 3Health News:Significantly higher success rates with artificial insemination 2Health News:PET outperforms CT in characterization of lung nodules 2
(Date:9/15/2014)... , Sept. 15, 2014 /PRNewswire-iReach/ -- Asthma ... persons of all ages, but most commonly starts ... characterized by narrowing of the airways, leading to ... lungs come into contact with endogenous and exogenous ... events, such as swelling of the airways, tightening ...
(Date:9/15/2014)... MedicOne Medical Response, a leading provider emergency and ... Inc. Magazine as one of the fastest growing ... - http://photos.prnewswire.com/prnh/20140914/145997 The ... with the largest revenue growth between 2010 and ... ambulance companies to make the list, achieved an ...
(Date:9/15/2014)... -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI ... 2014, regular quarterly dividend payment of $0.15 per share ... September 5, 2014, the record date. About ... of patents and royalty assets, consisting primarily of its ... with various biotechnology and pharmaceutical companies. PDL pioneered the  ...
Breaking Medicine Technology:Asthma Market to Reach 161.02 million Cases in 10MM by 2023 2Asthma Market to Reach 161.02 million Cases in 10MM by 2023 3Asthma Market to Reach 161.02 million Cases in 10MM by 2023 4Asthma Market to Reach 161.02 million Cases in 10MM by 2023 5MedicOne Medical Response Named to 2014 Inc. 5000 Fastest Growing Companies List 2MedicOne Medical Response Named to 2014 Inc. 5000 Fastest Growing Companies List 3PDL BioPharma Completes Regular Quarterly Dividend Payment 2
... 11, 2011 Vanda Pharmaceuticals Inc. (NASDAQ: ... Corporation, an affiliate of Vanda,s sublicensor Novartis Pharma ... the long-acting injectable (or depot) formulation of Fanapt® ... will evaluate the safety and pharmacokinetic profiles of ...
... 11, 2011 Merck (NYSE: MRK ), ... and Intercell AG (VSE: ICLL) today announced that following ... trial evaluating V710, an investigational vaccine for the prevention ... Monitoring Committee (DMC) recommended suspension of enrollment. Although the ...
Cached Medicine Technology:Vanda Pharmaceuticals Announces Commencement of Clinical Study of Long-Acting Injectable Formulation of Fanapt® 2Vanda Pharmaceuticals Announces Commencement of Clinical Study of Long-Acting Injectable Formulation of Fanapt® 3Update on Phase II/III Clinical Trial of Investigational Staphylococcus aureus Vaccine, V710 2Update on Phase II/III Clinical Trial of Investigational Staphylococcus aureus Vaccine, V710 3
...
...
... exercise BP monitor is designed to automatically ... diastolic BP along with heart rate. It's ... use in treadmill, ergometer and pharmacological stress ... use in research environments., ,Tango excels ...
...
Medicine Products: